Key facts
- This page summarizes Pascal Touchon's Form 4 filing for Atara Biotherapeutics, Inc. (ATRA).
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 14 Aug 2024, 18:00.
Pascal Touchon - 12 Aug 2024 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- ATRA
- Reported as of
- 12 Aug 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 14 Aug 2024, 18:00:00 UTC
- Prior SEC filing
- 20 May 2024
- Next SEC filing
- 20 Aug 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Chao, Attorney-in-Fact for Pascal Touchon
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Pascal Touchon filed Form 4 for Atara Biotherapeutics, Inc. (ATRA) on 14 Aug 2024.
Change
- Previous filing in this sequence was filed on 20 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ATRA
transaction
Derivative
Employee Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -9,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 12 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,000
- Exercise price
- $510.75
- Footnotes
- F1, F4
ATRA
transaction
Derivative
Employee Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -9,680
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 12 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,680
- Exercise price
- $303.75
- Footnotes
- F2, F4
ATRA
transaction
Derivative
Employee Stock Option (Right to Buy)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -7,075
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 12 Aug 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,075
- Exercise price
- $427.63
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
25% of the shares subject to the option vested on June 24, 2020, and the remaining shares vested in equal monthly installments over the following 36 months.
Footnote F2
1/48th of the shares subject to the stock option vested and became exercisable each month with the initial installment vesting on April 1, 2020, subject to the reporting person's continuous service.
Footnote F3
1/48th of the shares subject to the stock option vested and became exercisable each month with the initial installment vesting on April 1, 2021, subject to the reporting person's continuous service.
Footnote F4
This option was cancelled by mutual agreement of the Issuer and the reporting person, in exchange for which cancellation the reporting person will receive a total cash payment of $100 as consideration.